Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
16,600
+7,100
+75% +$764K ﹤0.01% 5126
2026
Q1
$973K Sell
9,500
-7,200
-43% -$734K ﹤0.01% 6551
2025
Q4
$1.68M Buy
16,700
+1,700
+11% +$168K ﹤0.01% 5147
2025
Q3
$1.3M Sell
15,000
-90,800
-86% -$7.18M ﹤0.01% 5775
2025
Q2
$8.07M Sell
105,800
-85,500
-45% -$6.26M ﹤0.01% 2405
2025
Q1
$13.6M Buy
191,300
+43,000
+29% +$3.36M ﹤0.01% 1641
2024
Q4
$11.6M Sell
148,300
-32,100
-18% -$3M ﹤0.01% 1738
2024
Q3
$18.5M Sell
180,400
-2,400
-1% -$199K ﹤0.01% 1304
2024
Q2
$13.9M Buy
182,800
+133,900
+274% +$9.52M ﹤0.01% 1662
2024
Q1
$3.67M Sell
48,900
-74,400
-60% -$5.92M ﹤0.01% 3084
2023
Q4
$9.07M Buy
123,300
+54,000
+78% +$3.34M ﹤0.01% 2076
2023
Q3
$3.19M Buy
+69,300
New +$3.08M ﹤0.01% 3283

Other funds holding NUVL

Jane Street's NUVL Position: Q2 2026 in Review

Jane Street reduced its Nuvalent (NUVL) stake by 91% in Q2 2026, selling an estimated $7.57M and leaving 6,798 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #6905.

Jane Street first reported a position in NUVL in Q2 2022 and has held it in 10 quarters since. The position peaked at $7.9M in Q1 2026. 292 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Jane Street held 6,798 shares of Nuvalent worth $840K as of Q2 2026.
  • Jane Street sold 70,340 Nuvalent shares in Q2 2026, an estimated $7.57M.
  • Nuvalent made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6905 holding.
  • Jane Street first reported a position in Nuvalent in Q2 2022 and has held it in 10 quarters since.
  • Jane Street's Nuvalent position peaked at $7.9M in Q1 2026.
  • 292 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.